The Motley Fool

Key Data Points

Primary metrics and data points about Protalix BioTherapeutics, Inc..
Current Price: $1.46
Prev Close: $1.43
Open: $1.44
Bid: $1.43
Ask: $1.85
Day's Range: $1.44 - $1.47
52wk Range: $1.33 - $3.00
Volume: 31,949
Avg Vol 106,485
Market Cap: $137M
P/E (ttm): -4.93
EPS (ttm): ($0.29)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Protalix BioTherapeutics, Inc. from Fool.com.

Business Summary

Industry, sector and description for Protalix BioTherapeutics, Inc..

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

PLX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Protalix BioTherapeutics, Inc..
CAPS Rating 3 out of 5
 
159 Outperform
70 Underperform
CAPS All Stars
 
33 Outperform
21 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David Aviezer, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Protalix BioTherapeutics, Inc.

Primary metrics and data points about Protalix BioTherapeutics, Inc..